Simultaneous blockade of both molecules improved antitumor immunity by decreasing the frequency of regulatory T cells (Tregs) in the tumor microenvironment and increasing the proportion and activity of CD8+ effector T cells [35]. Here, CD8A is linked to neoplasm.